[Questionnaire for assessing the risk of venous thromboembolism in hospitalized surgical and non-surgical patients in the 4th Hungarian antithrombotic guideline entitled "Risk reduction and treatment of venous thromboembolism"]
- PMID: 20705551
- DOI: 10.1556/OH.2010.28944
[Questionnaire for assessing the risk of venous thromboembolism in hospitalized surgical and non-surgical patients in the 4th Hungarian antithrombotic guideline entitled "Risk reduction and treatment of venous thromboembolism"]
Abstract
A large proportion of hospitalized surgical and medical patients are at risk for venous thromboembolism. Depending on the type of surgical intervention, venous thrombosis develops in 15-60% of surgical patients without prophylaxis. Although venous thromboembolism is most often considered to be associated with recent surgery or trauma, 50 to 70% of symptomatic thromboembolic events and 70 to 80% of fatal pulmonary embolisms occur in nonsurgical patients. International and national registries show that the majority of at-risk surgical patients actually received the appropriate thromboembolic prophylaxis. However, despite of international and national recommendations, prophylaxis was not provided for a large proportion of at-risk medical patients. The rate of medical patients receiving prophylaxis should be increased, and appropriate thrombosis prophylaxis should be offered to at-risk medical patients. The thrombosis risk assessment is an important tool to identify patients at increased risk for venous thromboembolism, to simplify decision making on prophylaxis administration, and to improve the adherence to guidelines. When the risk is recognized, if there is no contraindication, prophylaxis should be ordered. The 4th Hungarian Antithrombotic Guideline entitled "Risk reduction and treatment of thromboembolism" calls attention to the importance of risk assessment and for the first time it includes and recommends risk assessment models for hospitalized surgical and medical patients. The risk assessment models are presented and the evidence based data for the different risk factors included in these models are reviewed.
Similar articles
-
[Results of ENDORSE study in Hungary. Multinational, cross-sectional study to assess the prevalence of venous thromboembolism risk and prophylaxis in acute hospital care setting].Orv Hetil. 2008 Nov 2;149(44):2069-76. doi: 10.1556/OH.2008.28488. Orv Hetil. 2008. PMID: 18952526 Hungarian.
-
[Thromboembolism--risk, prevention and therapy. Practice Guideline].Orv Hetil. 2009 Dec 27;150(52):2335-404. doi: 10.1556/OH.2009.28789. Orv Hetil. 2009. PMID: 20031519 Hungarian. No abstract available.
-
A cross-sectional evaluation of venous thromboembolism risk and use of venous thromboembolism prophylaxis in hospitalized patients in Senegal.Arch Cardiovasc Dis. 2011 Oct;104(10):493-501. doi: 10.1016/j.acvd.2011.05.007. Epub 2011 Sep 1. Arch Cardiovasc Dis. 2011. PMID: 22044701
-
Anticoagulation therapy for prevention and treatment of venous thromboembolic events in cancer patients: a review of current guidelines.Cancer Treat Rev. 2009 Dec;35(8):754-64. doi: 10.1016/j.ctrv.2009.08.009. Epub 2009 Sep 16. Cancer Treat Rev. 2009. PMID: 19762155 Review.
-
A review of venous thromboembolism prophylaxis for hospitalized medical patients.Hosp Pract (1995). 2013 Aug;41(3):60-9. doi: 10.3810/hp.2013.08.1069. Hosp Pract (1995). 2013. PMID: 23948622 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical